Close
Show

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate


Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals,...

Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal


San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules...
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine

Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine


AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be...
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate

Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate


Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions...
Fujifilm to invest 100 billion yen to expand its large scale biologics production facility in Denmark

Fujifilm to invest 100 billion yen to expand its large scale biologics production facility...


FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million...

The University of Queensland, CEPI and CSL partner to advance development and manufacture of...


CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland announced that...
Astellas Efforts Against the Spread of the Coronavirus Disease (COVID-19)

Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for...


Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the...
Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801

Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801


Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a...
 Leinco Technologies and Vanderbilt University Medical Center partner to deliver rapid, point of care COVID-19 diagnostic test

Leinco Technologies and Vanderbilt University Medical Center partner to deliver rapid, point of care...


Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, conjugates and...
 COVID-19 Lead Program

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...